BirchBioMed's Unattributed Round

BirchBioMed raised a round of funding on September 20, 2017.

BirchBioMed is a clinical-stage biomedical company focused on the clinical evaluation, development and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transp…

Articles about BirchBioMed's Unattributed Round: